(Reuters) – Pfizer Inc will develop new vaccines targeting other viruses and pathogens using the messenger RNA technology behind its COVID-19 shot, the Wall Street Journal reported on Tuesday, citing the drugmaker’s chief executive officer, Albert Bourla.
The drugmaker declined to say which viruses it is pursuing, the Journal reported.
Pfizer did not immediately respond to a Reuters request for comment.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Anil D’Silva)
